掘金港股基金经理看好结构性机会

Core Viewpoint - The Hong Kong stock market is expected to present investment opportunities in 2026, particularly in sectors such as innovative pharmaceuticals, technology, and dividend assets, following a strong performance in 2025 [1][3]. Group 1: Market Performance - The Hong Kong stock market experienced a strong start in 2026, with the Hang Seng Index and Hang Seng Tech Index rising by 2.76% and 4% respectively on January 2, and year-to-date increases of 2.02% and 2.94% as of January 8 [1]. - In 2025, both the Hang Seng Index and Hang Seng Tech Index saw annual gains exceeding 20%, ranking among the top global markets [1]. Group 2: Fund Performance - Several funds investing in Hong Kong stocks achieved impressive returns in 2025, with the Huatai-PineBridge Hong Kong Advantage Selected Fund's A share returning 112.69% [2]. - Other notable funds, including the GF CSI Hong Kong Innovative Pharmaceuticals ETF and Southern Hong Kong Medical Industry A, reported returns over 60% [2]. - Cross-border ETFs focused on Hong Kong stocks attracted significant inflows, with the Hong Kong Stock Connect Internet ETF leading with a net inflow of 56.659 billion yuan in 2025 [2]. Group 3: Strategic Outlook - The overall sentiment towards the Hong Kong stock market remains optimistic, with expectations of continued inflows from southbound capital, which exceeded 1.3 trillion HKD in 2025 [3]. - Factors influencing the market include the Federal Reserve's monetary policy, domestic economic fundamentals, technology trends, and geopolitical situations, with a general positive outlook [4]. - The market's current valuation is considered attractive compared to global standards, providing potential investment opportunities [3][4]. Group 4: Sector Opportunities - Key sectors identified for investment include AI infrastructure, internet technology, new consumption, innovative pharmaceuticals, resource companies, and dividend-paying stocks [3]. - The non-bank financial sector and leading internet companies are viewed as having strong growth potential due to the rapid development of artificial intelligence [4]. - The innovative pharmaceutical sector is highlighted for its attractiveness, with a focus on companies with robust pipelines and cash flow improvements [4].